长江生命科技(0775.HK)罕见密会国际大行

格隆汇
28 Apr

格隆汇4月28日|据格隆汇独家获悉,一向低调埋首研发的长江生命科技,近日与十多家国际顶级投行进行了交流。有业内人士称,这家公司过去鲜少在资本市场抛头露面,如今突然高调与资本市场密会,背后必有深意。 长江生命科技管理层在会上系统阐述了公司多层次的发展策略: 长期战略布局方面,公司看重处于研发早期的创新性癌症疫苗,如近日公布的TROP2新型癌症疫苗研发项目。具备巨大潜力,有望成为公司未来的重磅产品。 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10